Foresight Diagnostics
Denver
About Foresight Diagnostics
Foresight Diagnostics develops a novel liquid biopsy test for the measurement of minimal residual disease to aid in patient management. They garnered significant partnering interest from multiple pharmaceutical companies in oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $104.2M
- Funding stage: M&A
- Last round: Series B (Jul 2024)
- Website: foresight-dx.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/foresight-diagnostics-58914 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.